Annual Results Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
343.43
224.53
196.99
192.90
166.73
165.98
Shareholder's Funds
343.43
224.53
196.99
192.90
166.73
165.98
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
72.44
72.45
30.22
20.16
0.61
0.28
Secured Loans
72.44
72.45
30.22
20.16
0.61
0.28
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
15.34
0.35
2.48
0.1
0.7
0.61
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
87.78
72.20
32.30
19.53
0.70
0.61
Current Liabilities
Trade Payables
16.39
27.74
18.15
5.27
2.86
2.24
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
135.69
80.61
36.94
15.43
11.48
5.39
Total Liabilities
566.90
377.35
266.22
227.86
178.91
171.97
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
23.84
4.84
4.64
2.08
2.05
1.37
Less: Accumulated Depreciation
2.10
1.98
1.29
0.55
0.22
0.13
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
21.75
2.87
3.35
1.53
1.83
1.24
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
5.87
5.56
0.63
0.48
0.66
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
4.39
3.53
1.51
0.48
0.46
0.08
Total Non-Current Assets
44.11
20.64
10.09
2.49
2.96
1.32
Current Assets Loans & Advances
Current Investments
233.63
196.56
2.50
145.37
0.48
0.00
Inventories
4.37
2.62
3.11
0.00
0.00
0.00
Sundry Debtors
85.06
46.76
16.62
0.00
0.00
0.00
Cash and Bank
184.20
94.82
224.95
71.66
171.33
168.15
Other Current Assets
509.31
342.06
248.26
220.61
171.91
168.17
Short Term Loans and Advances
2.05
1.30
1.09
0.00
0.00
0.00
Total Current Assets
522.78
356.70
256.13
225.38
175.95
170.66
Net Current Assets (Including Current Investments)
387.09
276.09
219.19
209.95
164.47
165.27
Total Current Assets Excluding Current Investments
522.78
356.70
256.13
225.38
175.95
170.66
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
566.90
377.35
266.22
227.86
178.91
171.97
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
72.44
72.45
30.22
20.16
0.61
0.28
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Compare Balance Sheet Results of Tarsus Pharmaceuticals, Inc.
Figures in Million
Consolidated - Balance Sheet Results
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
343.43
-438.17
781.60
178.38%
Shareholder's Funds
343.43
-438.17
781.60
178.38%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
72.44
587.11
-514.67
-87.66%
Secured Loans
72.44
587.11
-514.67
-87.66%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
15.34
6.72
8.62
128.27%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
87.78
565.93
-478.15
-84.49%
Current Liabilities
Trade Payables
16.39
4.98
11.41
229.12%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
135.69
132.04
3.65
2.76%
Total Liabilities
566.90
259.80
307.10
118.21%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
23.84
7.14
16.70
233.89%
Less: Accumulated Depreciation
2.10
3.48
-1.38
-39.66%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
21.75
3.67
18.08
492.64%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
5.87
2.86
3.01
105.24%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
4.39
23.65
-19.26
-81.44%
Total Non-Current Assets
44.11
30.83
13.28
43.07%
Current Assets Loans & Advances
Current Investments
233.63
0
233.63
0.00%
Inventories
4.37
5.52
-1.15
-20.83%
Sundry Debtors
85.06
78.13
6.93
8.87%
Cash and Bank
184.20
129.97
54.23
41.73%
Other Current Assets
509.31
213.62
295.69
138.42%
Short Term Loans and Advances
2.05
0
2.05
0.00%
Total Current Assets
522.78
228.97
293.81
128.32%
Net Current Assets (Including Current Investments)
387.09
96.93
290.16
299.35%
Total Current Assets Excluding Current Investments
522.78
228.97
293.81
128.32%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
566.90
259.80
307.10
118.21%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
72.44
587.11
-514.67
-87.66%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Analysis not available as Data has been published for only 1 period
Annual - Investments
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Analysis not available as Data has been published for only 1 period
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
